أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

clinigen healthcare b.v. - melatonin - oral solution - melatonin

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

مالطا - الإنجليزية - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics

مالطا - الإنجليزية - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - melatonin - prolonged-release tablet - melatonin

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ecolab pty ltd - alkaline salts - wettable powder - alkaline salts cleanser/sanitiser active 775.0 g/kg - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg;  ;   - modified release tablet - 2 mg - active: melatonin 2mg     excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - melatonin 2mg;   - modified release tablet - 2 mg - active: melatonin 2mg   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid copolymer purified talc - indicated as a monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients aged 55 years and over.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg;  ;   - modified release tablet - 2 mg - active: melatonin 2mg     excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - cyproheptadine hydrochloride - oral tablet - 4mg